Does the addition of fibrates to statin therapy have a favorable risk to benefit ratio? [electronic resource]
Producer: 20080515Description: 25-32 p. digitalISSN:- 1534-6242
- Atherosclerosis -- prevention & control
- Cardiovascular Diseases -- blood
- Cholesterol, HDL -- blood
- Clofibric Acid -- therapeutic use
- Diabetic Angiopathies -- prevention & control
- Drug Therapy, Combination
- Fenofibrate -- pharmacology
- Gemfibrozil -- pharmacology
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypolipidemic Agents -- therapeutic use
- Randomized Controlled Trials as Topic
- Rhabdomyolysis -- epidemiology
- Risk Assessment
- Triglycerides -- analysis
No physical items for this record
Publication Type: Journal Article; Review
There are no comments on this title.
Log in to your account to post a comment.